Qualifications and experience
- Cancers, Cancers - Leukemia (Adult Acute), Cancers - Myelodysplastic Syndrome, Hematology
Hospital of the University of Pennsylvania (2018)
University of Pennsylvania Program (2013)
Duke University School of Medicine (2012)
Hospital of the University of Pennsylvania (2015)
Duke University (NC) (2007)
University of Pennsylvania (2020)
- Clinical interest for patients
McMahon's primary clinical interests are in the management of acute leukemia and myelodysplastic syndromes.
- Research interest for patients
Dr. McMahon is focused on clinical trials and translational studies for AML and MDS. Her previous research has focused on mechanisms of response and resistance to FLT3 inhibitors in acute myeloid leukemia.